Back to Agenda
LS29 Has RMP Changed Post-Marketing Safety Management in Japan in the 10 Years Since it Started?
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor,Graduate School of Pharmaceutical Sciences
Kitasato University, Japan
Speaker(s)
Shinya Takemoto, MSc
Chugai Pharmaceutical Co., Ltd., Japan
Group Manager, Safety Information Strategy Group, Risk Communication Department
![Masahiro Hayashi, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Masahiro Hayashi, PhD
Toranomon Hospital, Japan
Pharmaceutical affairs specialist, Department of Pharmacy
Eiji Saito
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer
Have an account?